UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis

Diabetes & metabolism, 2017-02, Vol.43 (1), p.1-8

2017

Volltextzugriff (PDF)

Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors

Expert opinion on pharmacotherapy, 2016-08, Vol.17 (12), p.1581-1583

2016

Volltextzugriff (PDF)

Effects of evolving lipid-lowering drugs on carbohydrate metabolism

Diabetes research and clinical practice, 2018-03, Vol.137, p.1-9

2018

Volltextzugriff (PDF)

SGLT2 inhibitors and the kidney: Effects and mechanisms

Diabetes & metabolic syndrome clinical research & reviews, 2018-11, Vol.12 (6), p.1117-1123

2018

Volltextzugriff (PDF)

Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition

Current vascular pharmacology, 2017-01, Vol.15 (2), p.96

2017

Volltextzugriff (PDF)

SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms

Diabetes & metabolic syndrome clinical research & reviews, 2018-01, Vol.12 (1), p.59-63

2018

Volltextzugriff (PDF)

Influence of HDL-cholesterol levels on HDL particles lipid composition in healthy individuals. an NMR-based lipidomic study

Atherosclerosis, 2016-09, Vol.252, p.e110-e110

2016

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis

Atherosclerosis, 2016-09, Vol.252, p.e223-e223

2016

Volltextzugriff (PDF)

Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implications

International journal of clinical practice (Esher), 2009-06, Vol.63 (6), p.900-902

2009

Volltextzugriff (PDF)

Pleiotropic effects of fenofibrate

Current pharmaceutical design, 2009-02, Vol.15 (5), p.517

2009

Volltextzugriff (PDF)

Investigation of the presence of ischemic heart disease by the 1H NMR-based lipidomics of red blood cell membranes

Atherosclerosis, 2015-07, Vol.241 (1), p.e124-e125

2015

Volltextzugriff (PDF)

Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine

Nephrology, dialysis, transplantation, 2011-10, Vol.26 (10), p.3219-3224

2011

Volltextzugriff (PDF)

Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome

Lipids, 2009, Vol.44 (1), p.9-16

2009

Volltextzugriff (PDF)

High Doses of Rosuvastatin are Superior to Low Doses of Rosuvastatin Plus Fenofibrate or n-3 Fatty Acids in Mixed Dyslipidemia

Lipids, 2011-06, Vol.46 (6), p.521-528

2011

Volltextzugriff (PDF)

Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study

Scandinavian journal of rheumatology, 2013-01, Vol.42 (3), p.169-175

2013

Volltextzugriff (PDF)

Hypolipidemic treatment increases lipoprotein(a) levels in patients with mixed hyperlipidemia

Atherosclerosis, 2023-08, Vol.379, p.S46

2023

Volltextzugriff (PDF)

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

International journal of clinical practice (Esher), 2012-09, Vol.66 (9), p.843-853

2012

Volltextzugriff (PDF)

Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile

Nutrition, metabolism, and cardiovascular diseases, 2013-04, Vol.23 (4), p.330-336

2013

Volltextzugriff (PDF)

HDL lipidomic analysis in patients with type 2 diabetes mellitus receiving fixed-dose combination of insulin degludec and liraglutide

Atherosclerosis, 2020-12, Vol.315, p.e65-e65

2020

Volltextzugriff (PDF)

Fibrate treatment can increase serum creatinine levels

Nephrology, dialysis, transplantation, 2001-06, Vol.16 (6), p.1301-1301

2001

Volltextzugriff (PDF)

Cola soft drinks and hypokalaemia

International journal of clinical practice (Esher), 2009-10, Vol.63 (10), p.1545-1545

2009

Volltextzugriff (PDF)

Diagnostic lipid changes in patients with visceral leishmaniasis

Atherosclerosis, 2018-08, Vol.275, p.e150-e150

2018

Volltextzugriff (PDF)

URIC ACID LEVELS AND RENAL FUNCTION IN UNTREATED HYPERTENSIVE PATIENTS

Journal of hypertension, 2018-06, Vol.36 (Supplement 1), p.e143-e144

2018

Volltextzugriff (PDF)

Effect Of Anti-Hyperglycemic Agents On Serum Pcsk9 Levels

Atherosclerosis, 2019-08, Vol.287, p.e128-e128

2019

Volltextzugriff (PDF)

Effect Of The Fixed-Dose Combination Of Insulin Degludec And Liraglutide On Serum Lipoprotein Metabolism In Patients With Type 2 Diabetes Mellitus

Atherosclerosis, 2019-08, Vol.287, p.e127-e128

2019

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(64)
Buchkapitel
(1)

Sprache

Englisch
(65)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis

Mechanisms of blood pressure reduction with sodium-glucose co-transporter 2 (SGLT2) inhibitors

Effects of evolving lipid-lowering drugs on carbohydrate metabolism

SGLT2 inhibitors and the kidney: Effects and mechanisms

Renoprotective Effects of SGLT2 Inhibitors: Beyond Glucose Reabsorption Inhibition

SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms

Influence of HDL-cholesterol levels on HDL particles lipid composition in healthy individuals. an NMR-based lipidomic study

Dipeptidyl peptidase-4 inhibitors and protection against stroke: A systematic review and meta-analysis

Cola-induced hypokalaemia: pathophysiological mechanisms and clinical implications

Pleiotropic effects of fenofibrate

Investigation of the presence of ischemic heart disease by the 1H NMR-based lipidomics of red blood cell membranes

Aminoglycoside-induced nephrotoxicity studied by proton magnetic resonance spectroscopy of urine

Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome

High Doses of Rosuvastatin are Superior to Low Doses of Rosuvastatin Plus Fenofibrate or n-3 Fatty Acids in Mixed Dyslipidemia

Effects of 12 months of treatment with disease-modifying anti-rheumatic drugs on low and high density lipoprotein subclass distribution in patients with early rheumatoid arthritis: a pilot study

Hypolipidemic treatment increases lipoprotein(a) levels in patients with mixed hyperlipidemia

Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome

Increased plasma visfatin concentration is a marker of an atherogenic metabolic profile

HDL lipidomic analysis in patients with type 2 diabetes mellitus receiving fixed-dose combination of insulin degludec and liraglutide

Fibrate treatment can increase serum creatinine levels

Cola soft drinks and hypokalaemia

Diagnostic lipid changes in patients with visceral leishmaniasis

URIC ACID LEVELS AND RENAL FUNCTION IN UNTREATED HYPERTENSIVE PATIENTS

Effect Of Anti-Hyperglycemic Agents On Serum Pcsk9 Levels

Effect Of The Fixed-Dose Combination Of Insulin Degludec And Liraglutide On Serum Lipoprotein Metabolism In Patients With Type 2 Diabetes Mellitus

Suchergebnisse filtern